New ASMBS/IFSO guidance
Metabolic and Bariatric Surgery (MBS) recommended for individuals with BMI >35 kg/m2, regardless of presence or absence of comorbidities and should be considered for individuals with metabolic disease and BMI 30-34.9 kg/m2 who do not achieve substantial or durable weight loss or comorbidity improvement using nonsurgical methods.
BMI thresholds should be adjusted in the Asian population such that BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS.
Leave A Comment